SCHEMBL1990124

SCHEMBL1990124

CCN(CC)CCCS(=O)(=O)N[C@H](CCc1ccccc1)c1nc(Cc2cccc(OC)c2)no1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GHSR Q92847 1/20 0.56
SRC P12931 3/20 0.40
ZAP70 P43403 3/20 0.40
HTR6 P50406 1/20 0.39
ACHE P22303 1/20 0.38
ADRB2 P07550 1/20 0.38
ADRB1 P08588 1/20 0.38
ADRB3 P13945 1/20 0.38
PKM P14618 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
ALDH1A1 P00352 1/20 0.35
POLB P06746 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
NMT1 P30419 1/20 0.35
CTSD P07339 1/20 0.35
BACE1 P56817 1/20 0.35
BCHE P06276 1/20 0.35
MEN1 O00255 1/20 0.35
LMNA P02545 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1991756 0.92 GHSR (0.62) GHSRSRCZAP70ADRB2ADRB1
SCHEMBL1989518 0.89 GHSR (0.48) GHSRSRCZAP70L3MBTL1
SCHEMBL1993678 0.89 GHSR (0.48) GHSRSRCZAP70ADRB2ADRB1
SCHEMBL1994348 0.87 GHSR (0.54) GHSRSRCZAP70ACHEL3MBTL1
SCHEMBL1988473 0.86 GHSR (0.54) GHSRSRCZAP70L3MBTL1ALDH1A1
SCHEMBL1990054 0.86 GHSR (0.54) GHSRSRCZAP70L3MBTL1ALDH1A1
SCHEMBL1991024 0.85 GHSR (0.49) GHSRSRCZAP70L3MBTL1
SCHEMBL1988077 0.85 GHSR (0.55) GHSRSRCZAP70L3MBTL1ALDH1A1
SCHEMBL1996177 0.84 GHSR (0.46) GHSRSRCZAP70ADRB1ALDH1A1
SCHEMBL1989861 0.84 GHSR (0.50) GHSRSRCZAP70L3MBTL1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF SAUNDERS JEFFREY O 2011-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152232-A1 SULFONAMIDE COMPOUNDS AND USES THEREOF GHSR, GHRHR, SSTR2 GHSR 1/4885SRC 2407/4885ZAP70 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.